What Researchers Did
Researchers retrospectively evaluated the effectiveness of hyperbaric oxygen therapy in 16 patients with BK-virus-associated hemorrhagic cystitis after allogeneic hematopoietic stem cell transplantation.
What They Found
All 16 patients had macroscopic hematuria and BKV infection, receiving a median of 13 hyperbaric oxygen treatments. Fifteen patients (94%) experienced complete resolution of hematuria, and median urinary DNA BKV titers declined significantly after therapy (P<0.05). Patients who started treatment earlier after diagnosis responded sooner (P<0.05).
What This Means for Canadian Patients
For Canadian patients experiencing BK-virus-associated hemorrhagic cystitis after allogeneic stem cell transplantation, hyperbaric oxygen therapy could be a beneficial treatment option. This therapy may offer a reliable way to resolve hematuria and reduce viral titers in a condition that is often difficult to manage.
Canadian Relevance
This study does not have a direct Canadian connection.
Study Limitations
The study's retrospective design and small sample size limit the generalizability of its findings.